PSU Profiles
Keywords
Last Name
Institution

Rodrigue Mortel

TitleProfessor Emeritus
InstitutionCollege of Medicine
DepartmentMedicine
Address500 University Drive, Hershey, PA 17033
Mailbox: HU02
Phone7175315101

 Overview 
 overview
PREFERRED TITLE/ROLE:

Associate Dean Emeritus, Director Penn State Cancer Institute

EDUCATION:

M.D.


 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Zelmanowicz Ade M, Schiffman M, Herrero R, Goldstein AM, Sherman ME, Burk RD, Gravitt P, Viscidi R, Schwartz P, Barnes W, Mortel R, Silverberg SG, Buckland J, Hildesheim A. Family history as a co-factor for adenocarcinoma and squamous cell carcinoma of the uterine cervix: results from two studies conducted in Costa Rica and the United States. Int J Cancer. 2005 Sep 10; 116(4):599-605.
    View in: PubMed
  2. Carrington M, Wang S, Martin MP, Gao X, Schiffman M, Cheng J, Herrero R, Rodriguez AC, Kurman R, Mortel R, Schwartz P, Glass A, Hildesheim A. Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci. J Exp Med. 2005 Apr 4; 201(7):1069-75.
    View in: PubMed
  3. Lacey JV, Potischman N, Madigan MP, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Lurain JR, Fillmore CM, Sherman ME, Brinton LA. Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: results from a U.S. case-control study. Cancer Epidemiol Biomarkers Prev. 2004 Apr; 13(4):607-12.
    View in: PubMed
  4. Burk RD, Terai M, Gravitt PE, Brinton LA, Kurman RJ, Barnes WA, Greenberg MD, Hadjimichael OC, Fu L, McGowan L, Mortel R, Schwartz PE, Hildesheim A. Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix. Cancer Res. 2003 Nov 1; 63(21):7215-20.
    View in: PubMed
  5. Lacey JV, Swanson CA, Brinton LA, Altekruse SF, Barnes WA, Gravitt PE, Greenberg MD, Hadjimichael OC, McGowan L, Mortel R, Schwartz PE, Kurman RJ, Hildesheim A. Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix. Cancer. 2003 Aug 15; 98(4):814-21.
    View in: PubMed
  6. Altekruse SF, Lacey JV, Brinton LA, Gravitt PE, Silverberg SG, Barnes WA, Greenberg MD, Hadjimichael OC, McGowan L, Mortel R, Schwartz PE, Hildesheim A. Comparison of human papillomavirus genotypes, sexual, and reproductive risk factors of cervical adenocarcinoma and squamous cell carcinoma: Northeastern United States. Am J Obstet Gynecol. 2003 Mar; 188(3):657-63.
    View in: PubMed
  7. Wang SS, Hildesheim A, Gao X, Schiffman M, Herrero R, Bratti MC, Sherman ME, Barnes WA, Greenberg MD, McGowan L, Mortel R, Schwartz PE, Zaino RJ, Glass AG, Burk RD, Karacki P, Carrington M. Comprehensive analysis of human leukocyte antigen class I alleles and cervical neoplasia in 3 epidemiologic studies. J Infect Dis. 2002 Sep 1; 186(5):598-605.
    View in: PubMed
  8. Wang SS, Hildesheim A, Gao X, Schiffman M, Herrero R, Bratti MC, Sherman ME, Barnes WA, Greenberg MD, McGowan L, Mortel R, Schwartz PE, Zaino RJ, Glass AG, Burk RD, Karacki P, Carrington M. Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage. Cancer Epidemiol Biomarkers Prev. 2002 Apr; 11(4):419-20.
    View in: PubMed
  9. Dong SM, Pai SI, Rha SH, Hildesheim A, Kurman RJ, Schwartz PE, Mortel R, McGowan L, Greenberg MD, Barnes WA, Sidransky D. Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma. Cancer Epidemiol Biomarkers Prev. 2002 Jan; 11(1):3-6.
    View in: PubMed
  10. Podczaski E, Mortel R. Hormonal treatment of endometrial cancer: past, present and future. Best Pract Res Clin Obstet Gynaecol. 2001 Jun; 15(3):469-89.
    View in: PubMed
  11. Lacey JV, Frisch M, Brinton LA, Abbas FM, Barnes WA, Gravitt PE, Greenberg MD, Greene SM, Hadjimichael OC, McGowan L, Mortel R, Schwartz PE, Zaino RJ, Hildesheim A. Associations between smoking and adenocarcinomas and squamous cell carcinomas of the uterine cervix (United States). Cancer Causes Control. 2001 Feb; 12(2):153-61.
    View in: PubMed
  12. Gravitt PE, Lacey JV, Brinton LA, Barnes WA, Kornegay JR, Greenberg MD, Greene SM, Hadjimichael OC, McGowan L, Mortel R, Schwartz PE, Zaino R, Hildesheim A. Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction. Cancer Epidemiol Biomarkers Prev. 2001 Feb; 10(2):95-100.
    View in: PubMed
  13. Stryker JA, Mortel R. Survival following extended field irradiation in carcinoma of cervix metastatic to para-aortic lymph nodes. Gynecol Oncol. 2000 Dec; 79(3):399-405.
    View in: PubMed
  14. Lacey JV, Brinton LA, Mortel R, Berman ML, Wilbanks GD, Twiggs LB, Barrett RJ. Tubal sterilization and risk of cancer of the endometrium. Gynecol Oncol. 2000 Dec; 79(3):482-4.
    View in: PubMed
  15. Lacey JV, Brinton LA, Barnes WA, Gravitt PE, Greenberg MD, Hadjimichael OC, McGowan L, Mortel R, Schwartz PE, Kurman RJ, Hildesheim A. Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix. Gynecol Oncol. 2000 Apr; 77(1):149-54.
    View in: PubMed
  16. Lacey JV, Brinton LA, Abbas FM, Barnes WA, Gravitt PE, Greenberg MD, Greene SM, Hadjimichael OC, McGowan L, Mortel R, Schwartz PE, Silverberg SG, Hildesheim A. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev. 1999 Dec; 8(12):1079-85.
    View in: PubMed
  17. Hildesheim A, Schiffman M, Brinton LA, Fraumeni JF, Herrero R, Bratti MC, Schwartz P, Mortel R, Barnes W, Greenberg M, McGowan L, Scott DR, Martin M, Herrera JE, Carrington M. p53 polymorphism and risk of cervical cancer. Nature. 1998 Dec 10; 396(6711):531-2.
    View in: PubMed
  18. Zelmanowicz A, Hildesheim A, Sherman ME, Sturgeon SR, Kurman RJ, Barrett RJ, Berman ML, Mortel R, Twiggs LB, Wilbanks GD, Brinton LA. Evidence for a common etiology for endometrial carcinomas and malignant mixed mullerian tumors. Gynecol Oncol. 1998 Jun; 69(3):253-7.
    View in: PubMed
  19. Sturgeon SR, Sherman ME, Kurman RJ, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Brinton LA. Analysis of histopathological features of endometrioid uterine carcinomas and epidemiologic risk factors. Cancer Epidemiol Biomarkers Prev. 1998 Mar; 7(3):231-5.
    View in: PubMed
  20. Sherman ME, Sturgeon S, Brinton LA, Potischman N, Kurman RJ, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD. Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas. Mod Pathol. 1997 Oct; 10(10):963-8.
    View in: PubMed
  21. Sturgeon SR, Brinton LA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Lurain JR. Intrauterine device use and endometrial cancer risk. Int J Epidemiol. 1997 Jun; 26(3):496-500.
    View in: PubMed
  22. Hetzel DJ, Olt GJ, Sorosky JI, Mortel R, Singapuri K, Podczaski ES. Gestational trophoblastic disease presenting as a large metastasis to the finger. Gynecol Oncol. 1996 Oct; 63(1):123-6.
    View in: PubMed
  23. Potischman N, Hoover RN, Brinton LA, Siiteri P, Dorgan JF, Swanson CA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Persky V, Lurain JR. Case-control study of endogenous steroid hormones and endometrial cancer. J Natl Cancer Inst. 1996 Aug 21; 88(16):1127-35.
    View in: PubMed
  24. Ndubisi B, Kaminski PF, Olt G, Sorosky J, Singapuri K, Hackett T, Hetzel D, Zaino R, Mortel R, Podczaski E. Staging and recurrence of disease in squamous cell carcinoma of the vulva. Gynecol Oncol. 1995 Oct; 59(1):34-7.
    View in: PubMed
  25. Hackett TE, Olt G, Sorosky JI, Podczaski E, Harrison TA, Mortel R. Surgical predictors of para-aortic metastases in early-stage cervical carcinoma. Gynecol Oncol. 1995 Oct; 59(1):15-9.
    View in: PubMed
  26. Swanson CA, Potischman N, Barrett RJ, Berman ML, Mortel R, Twiggs LB, Wilbanks GD, Hoover RN, Brinton LA. Endometrial cancer risk in relation to serum lipids and lipoprotein levels. Cancer Epidemiol Biomarkers Prev. 1994 Oct-Nov; 3(7):575-81.
    View in: PubMed
  27. Sorosky JI, Olt GJ, Mortel R. Endometrial carcinoma and its precursors. Curr Ther Endocrinol Metab. 1994; 5:562-6.
    View in: PubMed
  28. Swanson CA, Wilbanks GD, Twiggs LB, Mortel R, Berman ML, Barrett RJ, Brinton LA. Moderate alcohol consumption and the risk of endometrial cancer. Epidemiology. 1993 Nov; 4(6):530-6.
    View in: PubMed
  29. Sturgeon SR, Brinton LA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD. Past and present physical activity and endometrial cancer risk. Br J Cancer. 1993 Sep; 68(3):584-9.
    View in: PubMed
  30. Satyaswaroop PG, Mortel R. Sex steroid receptors in endometrial carcinoma. Gynecol Oncol. 1993 Sep; 50(3):278-80.
    View in: PubMed
  31. Stehman FB, Bundy BN, Thomas G, Keys HM, d'Ablaing G, Fowler WC, Mortel R, Creasman WT. Hydroxyurea versus misonidazole with radiation in cervical carcinoma: long-term follow-up of a Gynecologic Oncology Group trial. J Clin Oncol. 1993 Aug; 11(8):1523-8.
    View in: PubMed
  32. Swanson CA, Potischman N, Wilbanks GD, Twiggs LB, Mortel R, Berman ML, Barrett RJ, Baumgartner RN, Brinton LA. Relation of endometrial cancer risk to past and contemporary body size and body fat distribution. Cancer Epidemiol Biomarkers Prev. 1993 Jul-Aug; 2(4):321-7.
    View in: PubMed
  33. Homesley HD, Bundy BN, Sedlis A, Yordan E, Berek JS, Jahshan A, Mortel R. Prognostic factors for groin node metastasis in squamous cell carcinoma of the vulva (a Gynecologic Oncology Group study) Gynecol Oncol. 1993 Jun; 49(3):279-83.
    View in: PubMed
  34. Stanford JL, Brinton LA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Hoover RN. Oral contraceptives and endometrial cancer: do other risk factors modify the association? Int J Cancer. 1993 May 8; 54(2):243-8.
    View in: PubMed
  35. Potischman N, Swanson CA, Brinton LA, McAdams M, Barrett RJ, Berman ML, Mortel R, Twiggs LB, Wilbanks GD, Hoover RN. Dietary associations in a case-control study of endometrial cancer. Cancer Causes Control. 1993 May; 4(3):239-50.
    View in: PubMed
  36. Brinton LA, Barrett RJ, Berman ML, Mortel R, Twiggs LB, Wilbanks GD. Cigarette smoking and the risk of endometrial cancer. Am J Epidemiol. 1993 Feb 1; 137(3):281-91.
    View in: PubMed
  37. Brinton LA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Lannom L, Hoover RN. Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study. Am J Obstet Gynecol. 1992 Nov; 167(5):1317-25.
    View in: PubMed
  38. Satyaswaroop PG, Clarke CL, Zaino RJ, Mortel R. Apparent resistance in human endometrial carcinoma during combination treatment with tamoxifen and progestin may result from desensitization following downregulation of tumor progesterone receptor. Cancer Lett. 1992 Feb 29; 62(2):107-14.
    View in: PubMed
  39. Homesley HD, Bundy BN, Sedlis A, Yordan E, Berek JS, Jahshan A, Mortel R. Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study). Am J Obstet Gynecol. 1991 Apr; 164(4):997-1003; discussion 1003-4.
    View in: PubMed
  40. Satyaswaroop PG, Mortel R. Hormonal treatment of endometrial carcinoma: an overview and new development in biology. J Steroid Biochem Mol Biol. 1990 Dec 20; 37(6):997-1001.
    View in: PubMed
  41. Podczaski E, Sexton M, Kaminski P, Singapuri K, Sorosky J, Larson J, Mortel R. Recurrent carcinoma of the vulva after conservative treatment for "microinvasive" disease. Gynecol Oncol. 1990 Oct; 39(1):65-8.
    View in: PubMed
  42. Misas JE, Larson JE, Podczaski E, Manetta A, Mortel R. Recurrent Paget disease of the vulva in a split-thickness graft. Obstet Gynecol. 1990 Sep; 76(3 Pt 2):543-4.
    View in: PubMed
  43. Podczaski E, Stryker JA, Kaminski P, Ndubisi B, Larson J, DeGeest K, Sorosky J, Mortel R. Extended-field radiation therapy for carcinoma of the cervix. Cancer. 1990 Jul 15; 66(2):251-8.
    View in: PubMed
  44. Podczaski E, Abt A, Kaminski P, Larson J, Sorosky J, DeGeest K, Mortel R. A patient with multiple, malignant melanomas of the lower genital tract. Gynecol Oncol. 1990 Jun; 37(3):422-6.
    View in: PubMed
  45. Podczaski E, Sees J, Kaminski P, Sorosky J, Larson JE, DeGeest K, Zaino RJ, Mortel R. Rhabdomyosarcoma of the uterus in a postmenopausal patient. Gynecol Oncol. 1990 Jun; 37(3):439-42.
    View in: PubMed
  46. Mortel R, Zaino RJ, Satyaswaroop PG. Designing a schedule of progestin administration in the control of endometrial carcinoma growth in the nude mouse model. Am J Obstet Gynecol. 1990 Apr; 162(4):928-34; discussion 934-6.
    View in: PubMed
  47. Asbury RF, Blessing JA, McGuire WP, Hanjani P, Mortel R. Aminothiadiazole (NSC 4728) in patients with advanced carcinoma of the endometrium. A phase II study of the Gynecologic Oncology group. Am J Clin Oncol. 1990 Feb; 13(1):39-41.
    View in: PubMed
  48. Larson JE, Whitney CW, Zaino R, Kaminski P, Podczaski E, Mortel R. Endometrial response to endogenous hormones after pelvic irradiation for genital malignancies. Gynecol Oncol. 1990 Jan; 36(1):106-9.
    View in: PubMed
  49. Podczaski E, Manetta A, Kaminski P, Ricelli A, Larson J, DeGeest K, Mortel R. Survival of patients with ovarian epithelial carcinomas after second-look laparotomy. Gynecol Oncol. 1990 Jan; 36(1):43-7.
    View in: PubMed
  50. Podczaski E, Stryker J, Banducci D, Kaminski P, Sorosky J, Larson E, Degeest K, Mortel R. Multimodality approach to a massive carcinoma of the vulva. Eur J Gynaecol Oncol. 1990; 11(6):415-9.
    View in: PubMed
  51. Creasman WT, Gall S, Bundy BN, Beecham J, Mortel R, Homesley HD. Second-look laparotomy in the patient with minimal residual stage III ovarian cancer (a Gynecologic Oncology Group Study). Gynecol Oncol. 1989 Dec; 35(3):378-82.
    View in: PubMed
  52. Anthopoulos AP, Manetta A, Larson JE, Podczaski ES, Bartholomew MJ, Mortel R. Pelvic exenteration: a morbidity and mortality analysis of a seven-year experience. Gynecol Oncol. 1989 Nov; 35(2):219-23.
    View in: PubMed
  53. Podczaski ES, Kaminski P, Manetta A, Louk D, Andrews C, Larson J, DeGeest K, Mortel R. Stage II endometrial carcinoma treated with external-beam radiotherapy, intracavitary application of cesium, and surgery. Gynecol Oncol. 1989 Nov; 35(2):251-4.
    View in: PubMed
  54. Larson JE, Podczaski ES, Manetta A, Whitney CW, Mortel R. Bowel obstruction in patients with ovarian carcinoma: analysis of prognostic factors. Gynecol Oncol. 1989 Oct; 35(1):61-5.
    View in: PubMed
  55. Manetta A, Podczaski ES, Larson JE, De Geest K, Mortel R. Scalene lymph node biopsy in the preoperative evaluation of patients with recurrent cervical cancer. Gynecol Oncol. 1989 Jun; 33(3):332-4.
    View in: PubMed
  56. Podczaski E, Whitney C, Manetta A, Larson JE, Kirk J, Stevens CW, Lyter J, Mortel R. Use of CA 125 to monitor patients with ovarian epithelial carcinomas. Gynecol Oncol. 1989 May; 33(2):193-7.
    View in: PubMed
  57. Zaino RJ, Feil PD, Clarke CL, Mortel R, Satyaswaroop PG. A polyclonal antiserum against the rabbit progesterone receptor recognizes the human receptor: immunohistochemical localization in rabbit and human uterus. Cell Biochem Funct. 1989 Apr; 7(2):147-52.
    View in: PubMed
  58. Omura GA, Bundy BN, Berek JS, Curry S, Delgado G, Mortel R. Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol. 1989 Apr; 7(4):457-65.
    View in: PubMed
  59. Podczaski ES, Palombo C, Manetta A, Andrews C, Larson J, DeGeest K, Mortel R. Assessment of pretreatment laparotomy in patients with cervical carcinoma prior to radiotherapy. Gynecol Oncol. 1989 Apr; 33(1):71-5.
    View in: PubMed
  60. Manetta A, Satyaswaroop PG, Hamilton T, Ozols R, Mortel R. Therapeutic effect of a radiolabeled monoclonal antibody on human ovarian cancer xenograft in nude mice. Gynecol Oncol. 1989 Mar; 32(3):368-70.
    View in: PubMed
  61. Podczaski ES, Woomert CA, Stevens CW, Manetta A, Larson JE, Zaino RJ, Mortel R. Management of malignant, mixed mesodermal tumors of the uterus. Gynecol Oncol. 1989 Feb; 32(2):240-4.
    View in: PubMed
  62. Manetta A, Abt AB, Mamourian AC, Podczaski ES, Larson JE, Misas JE, Mortel R. Pelvic fibromatosis: case report and review of literature. Gynecol Oncol. 1989 Jan; 32(1):91-4.
    View in: PubMed
  63. Satyaswaroop PG, Zaino RJ, Mortel R. Carcinoma of the endometrium and hormonal receptors. Cancer Treat Res. 1989; 49:71-92.
    View in: PubMed
  64. Malkasian GD, Knapp RC, Lavin PT, Zurawski VR, Podratz KC, Stanhope CR, Mortel R, Berek JS, Bast RC, Ritts RE. Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses: discrimination of benign from malignant disease. Am J Obstet Gynecol. 1988 Aug; 159(2):341-6.
    View in: PubMed
  65. Stehman FB, Bundy BN, Keys H, Currie JL, Mortel R, Creasman WT. A randomized trial of hydroxyurea versus misonidazole adjunct to radiation therapy in carcinoma of the cervix. A preliminary report of a Gynecologic Oncology Group study. Am J Obstet Gynecol. 1988 Jul; 159(1):87-94.
    View in: PubMed
  66. Zurawski VR, Knapp RC, Einhorn N, Kenemans P, Mortel R, Ohmi K, Bast RC, Ritts RE, Malkasian G. An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinoma. Gynecol Oncol. 1988 May; 30(1):7-14.
    View in: PubMed
  67. Zaino RJ, Clarke CL, Mortel R, Satyaswaroop PG. Heterogeneity of progesterone receptor distribution in human endometrial adenocarcinoma. Cancer Res. 1988 Apr 1; 48(7):1889-95.
    View in: PubMed
  68. Stryker JA, Bartholomew M, Velkley DE, Cunningham DE, Mortel R, Craycraft G, Shafer J. Bladder and rectal complications following radiotherapy for cervix cancer. Gynecol Oncol. 1988 Jan; 29(1):1-11.
    View in: PubMed
  69. Manetta A, Satyaswarcoop PG, Podczaski ES, Hamilton T, Ozols RF, Mortel R. Effect of alpha-difluoromethylornithine (DFMO) on the growth of human ovarian carcinoma. Eur J Gynaecol Oncol. 1988; 9(3):222-7.
    View in: PubMed
  70. Manetta A, Satyaswaroop PG, Hamilton T, Ozols R, Mortel R. Radioimaging of human ovarian carcinoma xenograft in nude mice. Gynecol Oncol. 1987 Nov; 28(3):292-9.
    View in: PubMed
  71. Podczaski ES, Stevens CW, Manetta A, Whitney CW, Larson JE, Mortel R. Use of second-look laparotomy in the management of patients with ovarian epithelial malignancies. Gynecol Oncol. 1987 Oct; 28(2):205-14.
    View in: PubMed
  72. Asbury RF, Blessing JA, Mortel R, Homesley HD, Malfetano J. Aminothiadiazole (NSC #4728) in patients with advanced cervical carcinoma. A phase II study of the Gynecologic Oncology Group. Am J Clin Oncol. 1987 Aug; 10(4):299-301.
    View in: PubMed
  73. Satyaswaroop PG, Zaino R, Clarke CL, Mortel R. Nude mouse system in the study of tumor biology, treatment strategies and progesterone receptor physiology in human endometrial carcinoma. J Steroid Biochem. 1987; 27(1-3):431-8.
    View in: PubMed
  74. Satyaswaroop PG, Zaino RJ, Mortel R. Steroid receptors and human endometrial carcinoma: studies in a nude mouse model. Cancer Metastasis Rev. 1987; 6(3):223-41.
    View in: PubMed
  75. Schuster JJ, Stryker JA, Demers LM, Mortel R. Absence of bile acid malabsorption as a late effect of pelvic irradiation. Int J Radiat Oncol Biol Phys. 1986 Sep; 12(9):1605-10.
    View in: PubMed
  76. Kreider JW, Howett MK, Lill NL, Bartlett GL, Zaino RJ, Sedlacek TV, Mortel R. In vivo transformation of human skin with human papillomavirus type 11 from condylomata acuminata. J Virol. 1986 Aug; 59(2):369-76.
    View in: PubMed
  77. Niloff JM, Knapp RC, Lavin PT, Malkasian GD, Berek JS, Mortel R, Whitney C, Zurawski VR, Bast RC. The CA 125 assay as a predictor of clinical recurrence in epithelial ovarian cancer. Am J Obstet Gynecol. 1986 Jul; 155(1):56-60.
    View in: PubMed
  78. Houts PS, Whitney CW, Mortel R, Bartholomew MJ. Former cancer patients as counselors of newly diagnosed cancer patients. J Natl Cancer Inst. 1986 May; 76(5):793-6.
    View in: PubMed
  79. Mortel R, Satyaswaroop PG, Clarke CL, Zaino RJ. Sex steroid receptors in normal and malignant endometrium. Ann Pathol. 1986; 6(2):109-14.
    View in: PubMed
  80. Kreider JW, Howett MK, Wolfe SA, Bartlett GL, Zaino RJ, Sedlacek T, Mortel R. Morphological transformation in vivo of human uterine cervix with papillomavirus from condylomata acuminata. Nature. 1985 Oct 17-23; 317(6038):639-41.
    View in: PubMed
  81. Zaino RJ, Satyaswaroop PG, Mortel R. Histologic response of normal human endometrium to steroid hormones in athymic mice. Hum Pathol. 1985 Sep; 16(9):867-72.
    View in: PubMed
  82. Whitney CW, Satyaswaroop PG, Mortel R. Plasminogen activator activity in human endometrial carcinoma. Gynecol Oncol. 1985 Sep; 22(1):97-104.
    View in: PubMed
  83. Mortel R, Satyaswaroop PG, Zaino R. Steroid receptors in endometrial carcinoma. Am J Obstet Gynecol. 1985 Apr 15; 151(8):1145-6.
    View in: PubMed
  84. Zaino RJ, Satyaswaroop PG, Mortel R. Hormonal therapy of human endometrial adenocarcinoma in a nude mouse model. Cancer Res. 1985 Feb; 45(2):539-41.
    View in: PubMed
  85. Satyaswaroop PG, Zaino RJ, Mortel R. Estrogen-like effects of tamoxifen on human endometrial carcinoma transplanted into nude mice. Cancer Res. 1984 Sep; 44(9):4006-10.
    View in: PubMed
  86. Husseinzadeh N, Nahhas WA, Velkley DE, Whitney CW, Mortel R. The preservation of ovarian function in young women undergoing pelvic radiation therapy. Gynecol Oncol. 1984 Jul; 18(3):373-9.
    View in: PubMed
  87. Zaino RJ, Satyaswaroop PG, Mortel R. Morphology of human uterine cancer in nude mice. Effects of hormone and antihormone treatment. Arch Pathol Lab Med. 1984 Jul; 108(7):571-8.
    View in: PubMed
  88. Nahhas WA, Zaino R, Mortel R. Residual carcinoma in the surgical specimen of patients with endometrial adenocarcinoma undergoing preoperative radiation therapy. A study of 80 patients and a literature review. Gynecol Oncol. 1984 Jun; 18(2):165-76.
    View in: PubMed
  89. Husseinzadeh N, Nahhas WA, Manders EK, Whitney CW, Mortel R. Spontaneous occurrence of synergistic bacterial gangrene following external pelvic irradiation. Obstet Gynecol. 1984 Jun; 63(6):859-62.
    View in: PubMed
  90. Mortel R, Zaino R, Satyaswaroop PG. Heterogeneity and progesterone-receptor distribution in endometrial adenocarcinoma. Cancer. 1984 Jan 1; 53(1):113-6.
    View in: PubMed
  91. Zaino RJ, Satyaswaroop PG, Mortel R. The relationship of histologic and histochemical parameters to progesterone receptor status in endometrial adenocarcinomas. Gynecol Oncol. 1983 Oct; 16(2):196-208.
    View in: PubMed
  92. Chung CK, Nahhas WA, Stryker JA, Mortel R. Treatment outcome of recurrent cervical cancer. J Surg Oncol. 1983 Sep; 24(1):5-10.
    View in: PubMed
  93. Husseinzadeh N, Zaino R, Nahhas WA, Mortel R. The significance of histologic findings in predicting nodal metastases in invasive squamous cell carcinoma of the vulva. Gynecol Oncol. 1983 Aug; 16(1):105-11.
    View in: PubMed
  94. Nahhas WA, Sharkey FE, Whitney CW, Husseinzadeh N, Chung CK, Mortel R. The prognostic significance of vascular channel involvement and deep stromal penetration in early cervical carcinoma. Am J Clin Oncol. 1983 Jun; 6(3):259-64.
    View in: PubMed
  95. Satyaswaroop PG, Mortel R. Creatine kinase activity in human endometrium: relative distribution in isolated glands and stroma. Am J Obstet Gynecol. 1983 May 15; 146(2):159-62.
    View in: PubMed
  96. Satyaswaroop PG, Zaino RJ, Mortel R. Human endometrial adenocarcinoma transplanted into nude mice: growth regulation by estradiol. Science. 1983 Jan 7; 219(4580):58-60.
    View in: PubMed
  97. Satyaswaroop PG, Wartell DJ, Mortel R. Distribution of progesterone receptor, estradiol dehydrogenase, and 20 alpha-dihydroprogesterone dehydrogenase activities in human endometrial glands and stroma: progestin induction of steroid dehydrogenase activities in vitro is restricted to the glandular epithelium. Endocrinology. 1982 Sep; 111(3):743-9.
    View in: PubMed
  98. Zaino RJ, Nahhas WA, Mortel R. Glassy cell carcinoma of the uterine cervix. An ultrastructural study and review. Arch Pathol Lab Med. 1982 May; 106(5):250-4.
    View in: PubMed
  99. Satyaswaroop PG, Mortel R. Failure of progestins to induce estradiol dehydrogenase activity in endometrial carcinoma, in vitro. Cancer Res. 1982 Apr; 42(4):1322-5.
    View in: PubMed
  100. Chung CK, Stryker JA, Nahhas WA, Cunningham DE, Mortel R. Analysis of residual disease following preoperative radiotherapy versus initial surgery in endometrial carcinoma. Int J Radiat Oncol Biol Phys. 1982 Feb; 8(2):213-8.
    View in: PubMed
  101. Zaino RJ, Husseinzadeh N, Nahhas W, Mortel R. Epithelial alterations in proximity to invasive squamous carcinoma of the vulva. Int J Gynecol Pathol. 1982; 1(2):173-84.
    View in: PubMed
  102. Chung CK, Nahhas WA, Zaino R, Stryker JA, Mortel R. Histologic grade and lymph node metastasis in squamous cell carcinoma of the cervix. Gynecol Oncol. 1981 Dec; 12(3):348-54.
    View in: PubMed
  103. Chung CK, Stryker JA, Cohen C, Mortel R. Malignant mesenchymoma developing 6 years after radical hysterectomy and postoperative radiotherapy for cervical carcinoma. Gynecol Oncol. 1981 Dec; 12(3):367-72.
    View in: PubMed
  104. Chung CK, Stryker JA, Nahhas WA, Mortel R. The role of adjunctive radiotherapy for stage I endometrial carcinoma: preoperative vs postoperative irradiation. Int J Radiat Oncol Biol Phys. 1981 Oct; 7(10):1429-35.
    View in: PubMed
  105. Curry SL, Rine J, Whitney CW, Nahhas WA, Mortel R, Demers LM. The role of prostaglandins in the excessive nausea and vomiting after intravascular cis-platinum therapy. Gynecol Oncol. 1981 Aug; 12(1):89-91.
    View in: PubMed
  106. Satyaswaroop PG, Mortel R. Endometrial carcinoma: an aberration of endometrial cell differentiation. Am J Obstet Gynecol. 1981 Jul 15; 140(6):620-3.
    View in: PubMed
  107. Chung CK, Stryker JA, Ward SP, Nahhas WA, Mortel R. Histologic grade and prognosis of carcinoma of the cervix. Obstet Gynecol. 1981 May; 57(5):636-42.
    View in: PubMed
  108. Nahhas WA, Chung CK, Stryker JA, Zaino R, Mortel R. Relationship between histologic grading and extrapelvic nodal metastases in cervical carcinoma. Gynecol Oncol. 1981 Apr; 11(2):191-4.
    View in: PubMed
  109. Mortel R, Levy C, Wolff JP, Nicolas JC, Robel P, Baulieu EE. Female sex steroid receptors in postmenopausal endometrial carcinoma and biochemical response to an antiestrogen. Cancer Res. 1981 Mar; 41(3):1140-7.
    View in: PubMed
  110. Curry SL, Zembo MM, Nahhas WA, Jahshan AE, Whitney CW, Mortel R. Second-look laparotomy for ovarian cancer. Gynecol Oncol. 1981 Feb; 11(1):114-8.
    View in: PubMed
  111. Whitney CW, Curry SL, Nahhas WA, Mortel R. Gynecologic malignancy metastatic to upper gastrointestinal tract mucosa. Gynecol Oncol. 1981 Feb; 11(1):124-5.
    View in: PubMed
  112. Curry SL, Nahhas WA, Jahshan AE, Whitney CW, Mortel R. Pelvic exenteration: a 7-year experience. Gynecol Oncol. 1981 Feb; 11(1):119-23.
    View in: PubMed
  113. Nahhas WA, Whitney CW, Stryker JA, Curry SL, Chung CK, Mortel R. Stage II endometrial carcinoma. Gynecol Oncol. 1980 Dec; 10(3):303-11.
    View in: PubMed
  114. Chung CK, Nahhas WA, Stryker JA, Curry SL, Abt AB, Mortel R. Analysis of factors contributing to treatment failures in stages IB and IIA carcinoma of the cervix. Am J Obstet Gynecol. 1980 Nov 1; 138(5):550-6.
    View in: PubMed
  115. Gautray JP, Mortel R, Robel P, Baulieu EE. Uterine receptors and fertility regulation. Acta Eur Fertil. 1980 Sep; 11(3):185-98.
    View in: PubMed
  116. Lévy C, Mortel R, Eychenne B, Robel P, Baulieu EE. Unoccupied nuclear oestradiol-receptor sites in normal human endometrium. Biochem J. 1980 Mar 1; 185(3):733-8.
    View in: PubMed
  117. Leary JF, Todd P, Ross GS, Mortel R, Fleagle GS. The use of percent volume analysis in Coulter sizing of cells in gynecologic cytopathologic cell suspensions. Anal Quant Cytol. 1979 Nov-Dec; 1(3):228-32.
    View in: PubMed
  118. Stryker JA, Demers LM, Mortel R. Prophylactic ibuprofen administration during pelvic irradiation. Int J Radiat Oncol Biol Phys. 1979 Nov-Dec; 5(11-12):2049-52.
    View in: PubMed
  119. Gorodecki J, Mortel R, Ladda RL, Ward SP, Geder L, Rapp F. Establishment and characterization of a new endometrial cancer cell line (SCRC-1). Am J Obstet Gynecol. 1979 Nov 1; 135(5):671-9.
    View in: PubMed
  120. Sall S, DiSaia P, Morrow CP, Mortel R, Prem K, Thigpen T, Creasman W. A comparison of medroxyprogesterone serum concentrations by the oral or intramuscular route in patients with persistent or recurrent endometrial carcinoma. Am J Obstet Gynecol. 1979 Nov 1; 135(5):647-50.
    View in: PubMed
  121. Kane R, Harvey H, Andrews T, Bernath A, Curry S, Dixon R, Gottlieb R, Kukrika M, Lipton A, Mortel R, Ricci J, White D. Phase II trial of cyclophosphamide, hexamethylmelamine, adriamycin, and cis-dichlorodiammineplatinum(II) combination chemotherapy in advanced ovarian carcinoma. Cancer Treat Rep. 1979 Feb; 63(2):307-9.
    View in: PubMed
  122. Feil PD, Mann WJ, Mortel R, Bardin CW. Nuclear progestin receptors in normal and malignant human endometrium. J Clin Endocrinol Metab. 1979 Feb; 48(2):327-34.
    View in: PubMed
  123. Notter MF, Docherty JJ, Mortel R, Hollinshead AC. Detection of herpes simplex virus tumor-associated antigen in uterine cervical cancer tissue: five case studies. Gynecol Oncol. 1978 Dec; 6(6):574-81.
    View in: PubMed
  124. Stryker JA, Mortel R, Hepner GW. The effect of pelvic irradiation on lactose absorption. Int J Radiat Oncol Biol Phys. 1978 Sep-Oct; 4(9-10):859-63.
    View in: PubMed
  125. Mann WJ, Mortel R, Ward SP, Feil PD. Concomitant existence of carcinoma and secretory endometrium. Gynecol Oncol. 1978 Jun; 6(3):275-81.
    View in: PubMed
  126. Williams GH, Hammond JM, Weisz J, Mortel R. Binding sites for lactogenic hormone in the rat uterus. Biol Reprod. 1978 May; 18(4):697-706.
    View in: PubMed
  127. Stryker JA, Hepner GW, Mortel R. The effect of pelvic irradiation on ileal function. Radiology. 1977 Jul; 124(1):213-6.
    View in: PubMed
  128. Allegra JC, Stryker JA, Abt A, Mortel R. Serum magnesium and irradiation. Radiology. 1977 Jul; 124(1):217-20.
    View in: PubMed
  129. Mortel R, Allegra JC, Demers LM, Harvey HA, Trautlein J, Nahhas W, White D, Gillin MA, Lipton A. Plasma prostaglandins across the tumor bed of patients with gynecologic malignancy. Cancer. 1977 May; 39(5):2201-3.
    View in: PubMed
  130. Demers LM, Allegra JC, Harvey HA, Lipton A, Luderer JR, Mortel R, Brenner DE. Plasma prostaglandins in hypercalcemic patients with neoplastic disease. Cancer. 1977 Apr; 39(4):1559-62.
    View in: PubMed
  131. Nahhas WA, Abt AB, Mortel R. Stage i B glassy cell carcinoma of the cervix with ovarian metastases. Gynecol Oncol. 1977 Mar; 5(1):87-91.
    View in: PubMed
  132. Lewis GC, Mortel R, Slack NH. Endometrial cancer: therapeutic decision and the staging process in "early" disease. Cancer. 1977 Feb; 39(2 Suppl):959-66.
    View in: PubMed
  133. Stryker JA, Abt AB, Allegra JC, Mortel R, Uhlin S, Hepner GW. The effect of prednisone and irradiation on the rectum in dogs. Radiology. 1976 Oct; 121(1):183-7.
    View in: PubMed
  134. Allegra J, Lipton A, Harvey H, Luderer J, Brenner D, Mortel R, Demers L, Gillin M, White D, Trautlein J. Decreased prevalence of immediate hypersensitivity (atopy) in a cancer population. Cancer Res. 1976 Sep; 36(9 pt.1):3225-6.
    View in: PubMed
  135. Lipton A, Sheehan L, Mortel R, Harvey HA. Urinary polyamine levels in patients with localized malignancy. Cancer. 1976 Sep; 38(3):1344-7.
    View in: PubMed
  136. Miller FJ, Mortel R, Mann WJ, Jahshan AE. Selective arterial embolization for control of hemorrhage in pelvic malignancy: femoral and brachial catheter approaches. AJR Am J Roentgenol. 1976 May; 126(5):1028-32.
    View in: PubMed
  137. Gillis H, Mortel R, McGavran MH. Maternal malignant melanoma metastatic to the products of conception. Report of a case. Gynecol Oncol. 1976 Mar; 4(1):38-42.
    View in: PubMed
  138. Boltz RC, Todd P, Gaines RA, Milito RP, Docherty JJ, Thompson CJ, Notter MF, Richardson LS, Mortel R. Cell electrophoresis research directed toward clinical cytodiagnosis. J Histochem Cytochem. 1976 Jan; 24(1):16-23.
    View in: PubMed
  139. Lewis GC, Slack NH, Mortel R, Bross ID. Adjuvant progestogen therapy in the primary definitive treatment of endometrial cancer. Gynecol Oncol. 1974 Aug; 2(2-3):368-76.
    View in: PubMed
  140. Mortel R, Koss LG, Lewis JL, D'Urso JR. Mesodermal mixed tumors of the uterine corpus. Obstet Gynecol. 1974 Feb; 43(2):248-52.
    View in: PubMed
  141. Antoniades J, Mortel R, Lewis GC, Brady LW, Faust DS, Prasasvinichai S, Torpie RJ, Asbell SO. The management of carcinoma involving the cervix and body of the uterus. Obstet Gynecol. 1973 Aug; 42(2):208-12.
    View in: PubMed
  142. Mortel R, Lewis GC, Brady LW. Evaluation of abdominal lymph scanning in gynecologic cancer. Gynecol Oncol. 1972 Nov; 1(1):36-43.
    View in: PubMed
  143. Kazem I, Nedwich A, Mortel R, Honda T. Comparative histological changes in the normal lymph node following ethiodol lymphography and colloidal gold-198 lymphscanning. Clin Radiol. 1971 Jul; 22(3):382-8.
    View in: PubMed
  144. Mortel R, Nedwich A, Lewis GC, Brady LW. Malignant mixed müllerian tumors of the uterine corpus. Obstet Gynecol. 1970 Mar; 35(3):468-80.
    View in: PubMed
Mortel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_